dr. axel grothey on bevacizumab beyond progression in metastatic colorectal cancer
Published 11 years ago • 420 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
2:03
dr. axel grothey on the side effect profile of regorafenib in metastatic colorectal cancer
-
4:28
introduction: bevacizumab versus cetuximab in metastatic colorectal cancer
-
4:16
fire-3 study: cetuximab versus bevacizumab in metastatic colorectal cancer
-
11:50
colon cancer management - dr. axel grothey, part 1
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
11:07
future analyses from the 80405 metastatic colorectal cancer trial
-
4:11
continuum of care in metastatic colorectal cancer
-
4:56
asco: pembrolizumab vs. chemotherapy for msi-h metastatic colorectal cancer
-
3:58
changing life after colorectal cancer: ron’s immunotherapy story
-
11:24
giant cell tumor of bone
-
32:43
colorectal cancer and immunotherapy with dr. scott kopetz
-
9:05
determining optimal treatments in metastatic colorectal cancer
-
6:17
colorectal cancer & ctdna updates with dr. axel grothey
-
29:15
icaho20 - asco direct™ highlights - dr. axel grothey - colorectal cancer
-
1:48
dr. grothey discusses novel agents for colorectal cancer
-
36:13
binaytara foundation_dr. axel grothey's talk on colon cancer
-
0:57
dr. axel grothey examines the use of adjuvant oxaliplatin in colon cancer
-
8:35
dr. axel grothey on the best of esmo gi
-
1:35
dr. eng on the treatment landscape in metastatic colorectal cancer
-
5:46
asco: binimetinib-containing triplet therapy for braf v600e metastatic colorectal cancer
-
7:37
debate: msi high colon cancer - upfront chemotherapy
-
0:57
dr. grothey on biomarkers to inform metastatic crc treatment decisions